Our results are consistent with these studies identifying ZFP36L1 as a tumor suppressor in SCLC, where it also possesses the ability to bind and downregulate mRNAs that promote SCLC neuroendocrine differentiation including INSM1 and SOX2. Here, ZFP36L1 is linked to small cell lung carcinoma.